Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression

Summary

Study to assess efficacy of Duloxetine 120 mg and Duloxetine 60 mg in patients hospitalized for severe depression after 4 weeks of treatment. To evaluate the rescue option in non-responding patients. Safety of Duloxetine will also be assessed.

Timeline

Start

2007-02-09

Primary completion

2008-08-26

Completion

2008-08-26

Outcome

Missed primary endpoint

registry analysis (other test); 60 mg Duloxetine vs 120 mg Duloxetine; p = 0.88; ANCOVA; note: p-value for treatment effect NCT02229825 ↗

Drugs

Indications